For more than two decades, scientists have explored a group of cancer drugs known as CD40 agonist antibodies. Early experiments suggested these treatments could strongly activate the immune system and help it destroy cancer cells. However,…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply